- Report
- March 2025
- 207 Pages
Global
From €4724EUR$4,950USD£3,958GBP
- Report
- August 2022
- 116 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- May 2022
- 118 Pages
Global
From €3436EUR$3,600USD£2,879GBP
- Report
- May 2022
- 56 Pages
Africa, Middle East
From €1432EUR$1,500USD£1,199GBP
- Report
- May 2022
- 56 Pages
Asia Pacific
From €1432EUR$1,500USD£1,199GBP
- Report
- May 2022
- 56 Pages
Europe
From €1432EUR$1,500USD£1,199GBP
- Report
- May 2022
- 51 Pages
North America
From €1432EUR$1,500USD£1,199GBP
- Report
- April 2022
- 205 Pages
Global
From €3407EUR$3,570USD£2,855GBP
The Postpartum Hemorrhage Device market is a subset of the larger Surgical Devices market. It includes devices used to treat postpartum hemorrhage, a condition that occurs when a woman experiences excessive bleeding after childbirth. These devices are used to reduce blood loss and help the patient recover. Common devices in this market include uterine balloon tamponade, uterine compression sutures, and uterine artery embolization. These devices are used to reduce blood loss and help the patient recover.
The Postpartum Hemorrhage Device market is highly competitive, with many companies offering a variety of products. Some of the major players in this market include Cook Medical, Medtronic, Stryker, and Boston Scientific. Other companies in the market include B. Braun, Merit Medical, and Smith & Nephew. Show Less Read more